Literature DB >> 20524021

Computer-aided molecular design of 1H-imidazole-2,4-diamine derivatives as potential inhibitors of Plasmodium falciparum DHFR enzyme.

Legesse Adane1, Prasad V Bharatam.   

Abstract

Design and discovery of new potential inhibitors of Plasmodium falciparum dihydrofolate reductase (PfDHFR), equally active against both the wild-type and mutant strains, is urgently needed. In this study, a computer-aided molecular design approach that involved ab initio molecular orbital and density functional theory calculations, along with molecular electrostatic potential analysis, and molecular docking studies was employed to design 15 1H-imidazole-2,4-diamine derivatives as potential inhibitors of PfDHFR enzyme. Visual inspection of the binding modes of the compounds demonstrated that they all interact, via H-bond interactions, with key amino acid residues (Asp54, Ileu/Leu164, Asn/Ser108 and Ile14) similar to those of WR99210 (3) in the active site of the enzymes used in the study. These interactions are known to be essential for enzyme inhibition. These compounds showed better or comparable binding affinities to that of the bound ligand (WR99210). In silico toxicity predictions, carried out using TOPKAT software, also indicated that the compounds are non-toxic.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524021     DOI: 10.1007/s00894-010-0756-y

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  49 in total

Review 1.  ADMET in silico modelling: towards prediction paradise?

Authors:  Han van de Waterbeemd; Eric Gifford
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

2.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

Authors:  Thomas A Halgren; Robert B Murphy; Richard A Friesner; Hege S Beard; Leah L Frye; W Thomas Pollard; Jay L Banks
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

4.  Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.

Authors:  Prashant V Desai; Akshay Patny; Jiri Gut; Philip J Rosenthal; Babu Tekwani; Anuradha Srivastava; Mitchell Avery
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

5.  Identification of the optimal third generation antifolate against P. falciparum and P. vivax.

Authors:  Sonia Y Hunt; Carsten Detering; Gabriele Varani; David P Jacobus; Guy A Schiehser; Hong-Ming Shieh; Isabelle Nevchas; Jacek Terpinski; Carol Hopkins Sibley
Journal:  Mol Biochem Parasitol       Date:  2005-09-06       Impact factor: 1.759

6.  Towards an understanding of drug resistance in malaria: three-dimensional structure of Plasmodium falciparum dihydrofolate reductase by homology building.

Authors:  T Lemcke; I T Christensen; F S Jørgensen
Journal:  Bioorg Med Chem       Date:  1999-06       Impact factor: 3.641

7.  Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance.

Authors:  G Rastelli; W Sirawaraporn; P Sompornpisut; T Vilaivan; S Kamchonwongpaisan; R Quarrell; G Lowe; Y Thebtaranonth; Y Yuthavong
Journal:  Bioorg Med Chem       Date:  2000-05       Impact factor: 3.641

8.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

9.  Interactions between cycloguanil derivatives and wild type and resistance-associated mutant Plasmodium falciparum dihydrofolate reductases.

Authors:  Phornphimon Maitarad; Sumalee Kamchonwongpaisan; Jarunee Vanichtanankul; Tirayut Vilaivan; Yongyuth Yuthavong; Supa Hannongbua
Journal:  J Comput Aided Mol Des       Date:  2009-01-21       Impact factor: 3.686

10.  Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.

Authors:  Ernest J Mui; Guy A Schiehser; Wilbur K Milhous; Honghue Hsu; Craig W Roberts; Michael Kirisits; Stephen Muench; David Rice; J P Dubey; Joseph W Fowble; Pradipsinh K Rathod; Sherry F Queener; Susan R Liu; David P Jacobus; Rima McLeod
Journal:  PLoS Negl Trop Dis       Date:  2008-03-05
View more
  5 in total

Review 1.  An epigrammatic status of the 'azole'-based antimalarial drugs.

Authors:  Mousmee Sharma; Parteek Prasher
Journal:  RSC Med Chem       Date:  2019-12-23

2.  2-Benzylidenebenzofuran-3(2H)-ones as a new class of alkaline phosphatase inhibitors: synthesis, SAR analysis, enzyme inhibitory kinetics and computational studies.

Authors:  Jamshaid Ashraf; Ehsan Ullah Mughal; Reem I Alsantali; Amina Sadiq; Rabab S Jassas; Nafeesa Naeem; Zaman Ashraf; Yasir Nazir; Muhammad Naveed Zafar; Amara Mumtaz; Masoud Mirzaei; Satar Saberi; Saleh A Ahmed
Journal:  RSC Adv       Date:  2021-10-29       Impact factor: 4.036

3.  Methylenedioxy Piperamide-Derived Compound D5 Regulates Inflammatory Cytokine Secretion in a Culture of Human Glial Cells.

Authors:  Sajad Shahbazi; Tara Zakerali
Journal:  Molecules       Date:  2022-05-30       Impact factor: 4.927

4.  VSDK: Virtual screening of small molecules using AutoDock Vina on Windows platform.

Authors:  Natsumi Baba; Eiichi Akaho
Journal:  Bioinformation       Date:  2011-08-02

5.  Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR.

Authors:  Temitope I David; Niyi S Adelakun; Olaposi I Omotuyi; Damilohun S Metibemu; Oluwafemi E Ekun; Gabriel O Eniafe; Olumide K Inyang; Bamidele Adewumi; Ojochenemi A Enejoh; Raymond T Owolabi; Eunice I Oribamise
Journal:  Bioinformation       Date:  2018-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.